Last updated October 7, 2026. Written and maintained by the Ultimate Male clinical team; regulatory lines are re-checked when the FDA acts.
What tesamorelin is
Tesamorelin is a stabilised version of growth hormone releasing hormone, the signal your hypothalamus sends to the pituitary to release growth hormone in pulses. Natural GHRH breaks down in minutes; tesamorelin carries a small chemical modification that lets it survive long enough to produce a solid pulse. It was developed by Theratechnologies, approved by the FDA in 2010 under the brand name Egrifta for reducing excess abdominal fat in HIV patients with lipodystrophy, and reformulated since (Egrifta SV, and in 2025 Egrifta WR). Compounding pharmacies also supply tesamorelin acetate for off-label use.
How tesamorelin reduces visceral fat
Growth hormone is strongly lipolytic, meaning it drives fat cells to release stored fat, and visceral fat, the kind packed around the organs, is especially responsive. By restoring a growth hormone pulse, tesamorelin raises IGF-1 and increases fat breakdown preferentially in the abdomen. Two things follow from the mechanism:
- It works through your own pituitary, so growth hormone stays within physiological pulses and the normal feedback loop remains intact, which is a safety advantage over injecting growth hormone itself
- It is specific to visceral fat; subcutaneous fat under the skin changes much less, which is why the tape measure moves more than the scale
- The effect lasts only while you take it; trials that stopped the drug saw visceral fat return within months
What the research shows
Tesamorelin has the best human evidence of anything on our peptide menu. Two phase 3 trials in HIV patients showed visceral adipose tissue fell by roughly 15 to 18 percent over 26 weeks versus a small increase on placebo, with improvements in triglycerides and waist circumference, and the effect was maintained to 52 weeks in those who continued. A separate trial in otherwise healthy older adults found improved scores on some tests of memory and executive function after 20 weeks, which is why cognition is sometimes mentioned. A study in non-HIV adults with abdominal obesity also showed visceral fat reduction. What has not been shown is a benefit for men who are already lean, or any effect on subcutaneous fat worth paying for.
How we use tesamorelin at Ultimate Male
Tesamorelin needs more monitoring than the recovery peptides, so the work-up is thorough:
- Baseline labs: IGF-1, fasting glucose and HbA1c, lipids, testosterone and a general panel; the consultation screens for cancer history and pituitary conditions
- Dose: 1 to 2 mg by subcutaneous injection once daily, usually at bedtime to line up with your natural growth hormone pulse
- Repeat IGF-1 and glucose at six to eight weeks, then every three months; the dose is adjusted to keep IGF-1 in the upper-normal range, never above it
- Progress is measured with waist circumference and, where available, a body-composition scan rather than the scale
- Frequently paired with TRT in men who have both low testosterone and central fat, and with a medical weight-loss plan
Where the FDA stands on tesamorelin
Tesamorelin is an FDA-approved drug, which places it in a different category from the compounded peptides on this site. The approval covers reduction of excess abdominal fat in adults with HIV and lipodystrophy. Using it for body composition in men without HIV is off-label: legal when a licensed provider judges it appropriate, but outside the approved indication, and your provider says so at the consultation. Compounded tesamorelin is supplied by 503A pharmacies; as of October 7, 2026 it remains available, and because an approved version exists, its compounding status is more settled than that of BPC-157 or TB-500.
Side effects and who should skip it
The most common effects are injection-site redness or itching, joint aches, swelling in the hands or feet from fluid retention, and tingling in the fingers; these are growth hormone effects and usually ease with a lower dose. Tesamorelin can raise blood sugar, which is why we check glucose and HbA1c and are cautious in men with prediabetes. It is not recommended for men with active cancer, a pituitary tumour or injury, or uncontrolled diabetes, and it is contraindicated in pregnancy, which is not relevant to our patients but is part of the label.
What men use Tesamorelin for
Is Tesamorelin for me?
It may be a good fit if any of these sound like you. Labs and a consultation decide.
- Men with a hard, protruding belly who are otherwise not overweight, the classic visceral-fat pattern
- Men on TRT whose energy and strength improved but whose midsection did not
- Men with high triglycerides and waist circumference over 40 inches who want a medical option alongside diet and training
- Men in their forties and fifties with declining IGF-1 on labs and a growing waist
- Men who have ruled out HGH because of the risks and want the physiological alternative
Who should not use it
- Active cancer or a cancer history under five years, because growth hormone and IGF-1 are growth signals
- Pituitary tumour, surgery or radiation
- Uncontrolled diabetes or rising HbA1c
- Men who are already lean and want a cosmetic edge: the trials show no meaningful effect there
How it starts
A free ten-minute phone call, then labs and a one-on-one consultation with a provider in San Gabriel or Downey. Tesamorelin is recommended only if your results and goals point to it.







